Crescitelli, Rossella http://orcid.org/0000-0002-1714-3169
Lässer, Cecilia http://orcid.org/0000-0003-1279-1746
Lötvall, Jan
Article History
Received: 9 July 2020
Accepted: 16 November 2020
First Online: 25 January 2021
Competing interests
: The authors have developed multiple EV-associated patents for putative clinical utilization: US20200088734A1, United States, R.C., J.L.; WO2020146390A1, WIPO (PCT), R.C., J.L.; GB2574785A, United Kingdom, C.L., J.L.; US20070298118A1, United States, J.L.; CA3017586A1, Canada, J.L.; US20200163998A1, United States, J.L.; and WO2014076137A1, WIPO (PCT), J.L. J.L. owns equity in Codiak BioSciences Inc. and Exocure Biosciences Inc. and consults in the field of EVs through Vesiclebio AB. R.C. and C.L. own equity in Exocure Bioscience Inc.